Jinyu Bio-Technology Co's quarterly market cap
increased
from Sep. 2025 (¥10,717 Mil) to Dec. 2025 (¥16,754 Mil) but then
declined
from Dec. 2025 (¥16,754 Mil) to Mar. 2026 (¥16,009 Mil).
Jinyu Bio-Technology Co's annual market cap
declined
from Dec. 2023 (¥12,066 Mil) to Dec. 2024 (¥7,686 Mil) but then
increased
from Dec. 2024 (¥7,686 Mil) to Dec. 2025 (¥16,754 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jinyu Bio-Technology Co's Enterprise Value for Today is ¥11,903 Mil.
Jinyu Bio-Technology Co (SHSE:600201) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Jinyu Bio-Technology Co Market Cap Related Terms
Jinyu Bio-Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600201 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Jinyu Bio-Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinyu Bio-Technology Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Jinyu Bio-Technology Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Jinyu Bio-Technology Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinyu Bio-Technology Co (SHSE:600201) has a Market Cap of ¥13,297 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jinyu Bio-Technology Co and its competitors. According to the industry distribution chart, Jinyu Bio-Technology Co ranks #176 out of 1427 companies in the Biotechnology industry, placing it in the top 12.3%.
Is Jinyu Bio-Technology Co's Market Cap too high?
Jinyu Bio-Technology Co's current Market Cap is ¥13,297 Mil. Based on the distribution chart, Jinyu Bio-Technology Co ranks #176 out of 1427 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jinyu Bio-Technology Co ranks #176 out of 1427 companies for Market Cap. This places Jinyu Bio-Technology Co in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jinyu Bio-Technology Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinyu Bio-Technology Co's current Market Cap is ¥13,297 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.23, compared to a current price of ¥11.96 — trading 45.3% above its estimated fair value. The current Market Cap is ¥13,297 Mil. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Market Cap is ¥13,297 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥11.96 is trading 45.3% above its estimated GF Value™ of ¥8.23.
GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:600201:
Market Cap: ¥13,297 Mil
GF Value™: ¥8.23 vs. price of ¥11.96 (45.3% above fair value)
No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score
Get the complete analysis for SHSE:600201
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600201 has been successfully added to your 
